Apogee Therapeutics Inc. is a clinical-stage biotechnology company developing differentiated biologics for inflammatory and immune diseases. It focuses on advancing novel antibody therapeutics targeti... Apogee Therapeutics Inc. is a clinical-stage biotechnology company developing differentiated biologics for inflammatory and immune diseases. It focuses on advancing novel antibody therapeutics targeting well-established biological drivers to address conditions with high unmet needs, including atopic dermatitis, chronic obstructive pulmonary disease, asthma, and other dermatological, respiratory, and gastroenterological disorders. The company's pipeline aims to improve treatment standards by optimizing antibodies for potentially superior efficacy and reduced dosing frequency compared to existing options. Apogee Therapeutics Inc. emphasizes creating therapies that enhance patient lives through innovative approaches in immunology. Its team consists of experienced clinical, commercial, scientific, and operational leaders committed to excellence in drug development. Headquartered in Waltham, Massachusetts, and founded in 2022, the company operates in the biotech sector dedicated to reshaping care for immune-mediated diseases.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

No Greenhouse Gas (GHG) Emissions data disclosed by Apogee Therapeutics

We reviewed Apogee Therapeutics's website and available disclosure materials for the 2023 reporting period and did not identify any reported Greenhouse Gas (GHG) Emissions data.

If you would like us to review newly published materials or reassess the most recent disclosures, you can submit a data update request.

Would you like us to review Apogee Therapeutics's data?

Start your 30-day free trial to request a data review for Apogee Therapeutics.

Start Free Trial

Legal Center Contact Us